Brokerages Set EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) PT at $26.63
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has received a consensus rating of “Buy” from the nine brokerages that are currently covering the firm, MarketBeat.com reports. Nine equities research analysts have rated the stock with a buy rating. The average 1 year price objective among brokerages that have issued a report on the stock […]
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has received a consensus rating of “Buy” from the nine brokerages that are currently covering the firm, MarketBeat.com reports. Nine equities research analysts have rated the stock with a buy rating. The average 1 year price objective among brokerages that have issued a report on the stock […]
